1382978-22-4

Basic information

• Product Name: C₁₈H₁₉ClN₂O₂
• CAS NO: 1382978-22-4
• Molecular Weight: 330.814
• Mol File: 1382978-22-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₁₈H₁₉ClN₂O₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₈H₁₉ClN₂O₂(1382978-22-4)
• EPA Substance Registry System: C₁₈H₁₉ClN₂O₂(1382978-22-4)

Safety Data

• Hazardous Substances Data: 1382978-22-4(Hazardous Substances Data)

Upstream product

• 87199-17-5 4-formylphenylboronic acid, 
• 870-46-2 t-butoxycarbonylhydrazine 
• 400744-49-2 3'-chloro-[1,1'-biphenyl]-4-carbaldehyde 
• 108-37-2 1-bromo-3-chlorobenzene 

Downstream Products

• 1462885-96-6 (R)-3-{N-(3'-chlorobiphenyl-4-ylmethyl)-N'-[3-(4-methoxybenzyloxy)isoxazole-5-carbonyl]hydrazino}-2-hydroxypropionic acid isopropyl ester 

Relevant articles and documents

CRYSTALLINE FORMS OF (R)-3-[N-(3'-CHLOROBIPHENYL-4-YLMETHYL)-N'-(3-HYDROXYISOXAZOLE-5-CARBONYL)HYDRAZINO]-2-HYDROXYPROPIONIC ACID ISOPROPYL ESTER

The invention provides crystalline forms of (R)-3-[N-(3′-chlorobiphenyl-4-ylmethyl)-N′—(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxypropionic acid isopropyl ester. This invention also provides pharmaceutical compositions comprising the crystalline compound, processes and intermediates for preparing the crystalline compound, and methods of using the crystalline compound to treat diseases.